Details of Host Protein
Host Protein General Information (ID: PT0648) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
Extracellular signal-regulated kinase 2 (ERK2)
|
Gene Name |
MAPK1
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
MK01_HUMAN
|
||||||
Protein Families |
Protein kinase superfamily
|
||||||||
EC Number |
2.7.11.24
|
||||||||
Subcellular Location |
Cytoplasm; cytoskeleton; spindle Nucleus Cytoplasm; cytoskeleton
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Serine/threonine kinase which acts as an essential componentof the MAP kinase signal transduction pathway. MAPK1/ERK2 andMAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERKcascade. They participate also in a signaling cascade initiated byactivated KIT and KITLG/SCF. Depending on the cellular context, theMAPK/ERK cascade mediates diverse biological functions such as cellgrowth, adhesion, survival and differentiation through the regulationof transcription, translation, cytoskeletal rearrangements. TheMAPK/ERK cascade plays also a role in initiation and regulation ofmeiosis, mitosis, and postmitotic functions in differentiated cells byphosphorylating a number of transcription factors. About 160 substrateshave already been discovered for ERKs. Many of these substrates arelocalized in the nucleus, and seem to participate in the regulation oftranscription upon stimulation. However, other substrates are found inthe cytosol as well as in other cellular organelles, and those areresponsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation ofthe endosomal dynamics, including lysosome processing and endosomecycling through the perinuclear recycling compartment (PNRC); as wellas in the fragmentation of the Golgi apparatus during mitosis. Thesubstrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (suchas BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators oftranslation (such as EIF4EBP1) and a variety of other signaling-relatedmolecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such asRAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 orMAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) areother substrates which enable the propagation the MAPK/ERK signal toadditional cytosolic and nuclear targets, thereby extending thespecificity of the cascade. Mediates phosphorylation of TPR in responseto EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading toPML degradation. Phosphorylates CDK2AP2.
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
Coronavirus disease - COVID-19 | hsa05171 | Pathway Map | |||||||
Chemokine signaling pathway | hsa04062 | Pathway Map | |||||||
Platelet activation | hsa04611 | Pathway Map | |||||||
Neutrophil extracellular trap formation | hsa04613 | Pathway Map | |||||||
Toll-like receptor signaling pathway | hsa04620 | Pathway Map | |||||||
NOD-like receptor signaling pathway | hsa04621 | Pathway Map | |||||||
C-type lectin receptor signaling pathway | hsa04625 | Pathway Map | |||||||
Natural killer cell mediated cytotoxicity | hsa04650 | Pathway Map | |||||||
IL-17 signaling pathway | hsa04657 | Pathway Map | |||||||
Th1 and Th2 cell differentiation | hsa04658 | Pathway Map | |||||||
Th17 cell differentiation | hsa04659 | Pathway Map | |||||||
T cell receptor signaling pathway | hsa04660 | Pathway Map | |||||||
B cell receptor signaling pathway | hsa04662 | Pathway Map | |||||||
Fc epsilon RI signaling pathway | hsa04664 | Pathway Map | |||||||
Fc gamma R-mediated phagocytosis | hsa04666 | Pathway Map | |||||||
Hepatitis C | hsa05160 | Pathway Map | |||||||
Hepatitis B | hsa05161 | Pathway Map | |||||||
Human cytomegalovirus infection | hsa05163 | Pathway Map | |||||||
Influenza A | hsa05164 | Pathway Map | |||||||
Human papillomavirus infection | hsa05165 | Pathway Map | |||||||
Human T-cell leukemia virus 1 infection | hsa05166 | Pathway Map | |||||||
Kaposi sarcoma-associated herpesvirus infection | hsa05167 | Pathway Map | |||||||
Human immunodeficiency virus 1 infection | hsa05170 | Pathway Map | |||||||
Viral carcinogenesis | hsa05203 | Pathway Map | |||||||
Pathogenic Escherichia coli infection | hsa05130 | Pathway Map | |||||||
3D Structure |
|
Function of This Protein During Virus Infection | |||||||||
---|---|---|---|---|---|---|---|---|---|
Virus Name | SARS-COV-2 | Protein Function | Anti-viral | [1] | |||||
Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
Method Description | To detect the role of host protein MAPK1 in viral infection, MAPK1 protein knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
Results | It is reported that knockout of MAPK1 increases SARS-CoV-2 RNA levels compared with control group. |
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: Not Specified Virus Region (hCoV-19/USA/WA1/2020 ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [2] | |||||||
Strains Name |
hCoV-19/USA/WA1/2020
|
||||||||
Strains Family |
Alpha (B.1.1.7)
|
||||||||
RNA Binding Region |
Not Specified Virus Region
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Huh7.5 cells (Hepatocyte derived cellular carcinoma cell) (CVCL_7927 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Infection Time | 48 h | ||||||||
Interaction Score | FDR ≤ 0.05 | ||||||||
Method Description | comprehensive identification of RNA-binding proteins by massspectrometry (ChIRP-MS) |
Differential Gene Expression During SARS-COV-2 Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Protein Phosphorylation after Virus Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T185
[3] |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Y187
[4] |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Y187
[3] |
Potential Drug(s) that Targets This Protein | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Name | DrunkBank ID | Pubchem ID | TTD ID | REF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aceclofenac | DB06736 | 71771 | D0T8VY | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Benzbromarone | DB12319 | 2333 | D0Z3DY | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bithionol | DB04813 | 2406 | D0QQ1J | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dicoumarol | DB00266 | 54676038 | D02TJS | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diiodoquin | DB09115 | 3728 | D06AEB | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exisulind | DB06246 | 5472495 | D0M9VE | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Isotretinoin | DB00982 | 5282379 | D00DKK | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meclofenamic acid | DB00939 | 4037 | D08IFL | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nabac | DB00756 | 3598 | D0ZX2G | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ravoxertinib | DB15281 | 71727581 | . | [4] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retinoic acid | DB00755 | 444795 | D02DGU | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sorafenib | DB00398 | 216239 | D0W5HK | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sulfasalazine | DB00795 | 5339 | D02ZTJ | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tannic acid | DB09372 | 16129778 | D0R4WJ | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Troglitazone | DB00197 | 5591 | D06XZW | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zafirlukast | DB00549 | 5717 | D05DVP | [2] |
Protein Sequence Information |
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
Click to Show/Hide
|
---|